Comprehensive Geriatric Assessment and Management for Canadian Elders With Cancer

University of Toronto

Status: Completed

Conditions: Cancer

Treatments: Other: Geriatric assessment and management

Study type: Interventional

Funder types: Other

Identifiers

NCT03154671

705046

Details and patient eligibility

About

A multicentre two-group parallel single-blind (outcome assessor) randomized controlled trial (RCT). A cost effectiveness study alongside a clinical trial using a payer and societal perspective to study the cost-effectiveness of geriatric assessment and management compared to usual care will be conducted.

Participants allocated to the control group will receive usual oncology care. Participants allocated to the intervention group will receive a comprehensive geriatric assessment and management in addition to their usual oncology care. The intervention will take 6 months to be completed. Total study follow-up will be 12 months for each participant.

Enrollment: 351 patients

Sex: All

Ages: 70+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 70+ with any solid tumor (excluding pancreatic) or lymphoma/myeloma referred for first/second line adjuvant/curative or palliative chemotherapy (cannot have received more than 1 cycle),
• Able to speak English/French,
• Have a physician-estimated life expectancy >6 months,
• Have an ECOG Performance Score 0-2 (indicating participants are ambulatory and able to complete all self-care activities),
• Able to give informed consent.

Exclusion criteria

• Receiving palliative care services upon recruitment
• Already participating in another psychosocial/educational intervention study (new treatment study is allowed if the participants would like to participate in 2 studies)

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

351 participants in 2 patient groups

Intervention group

Experimental group

Description:

At study enrollment participants allocated to the intervention arm will complete a comprehensive geriatric assessment with the study intervention team (nurse and physician). Based on these findings a care plan tailored to the needs of the older adult with cancer will be developed and implemented. The study intervention nurse will call the participant at least monthly to follow up and evaluate the care (e.g. whether adjustments are required) and more if needed. All participants will receive a monthly healthy aging newsletter.

Treatment:

Other: Geriatric assessment and management

Control group

No Intervention group

Description:

The participant will receive usual care from their treating oncology team. All participants will receive a monthly healthy aging newsletter.